Lantern Pharma Inc. Basic Shares Outstanding (Weighted Average)
Lantern Pharma Inc. (LTRN) reported Basic Shares Outstanding (Weighted Average) of 12.42 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 12.42M shares, a 15.19% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.25M shares, a 4.34% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.19M shares, a 3.76% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 10.83M shares, a 0.65% increase year-over-year.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 10.90M shares, a 1.26% increase from fiscal 2024.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 10.76M shares, a 0.74% decline from fiscal 2023.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 10.84M shares, a 0.08% decline from fiscal 2022.
- Lantern Pharma Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 10.85M shares, a 0.50% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 12.42M shares 10-Q · filed 2026-08-14 | 11.84M shares 10-Q · filed 2026-08-14 | 11.62M shares derived: average of 3 quarters · filed 2026-08-14 | 11.42M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 11.25M shares 10-Q · filed 2026-05-15 | 11.22M shares derived: average of 2 quarters · filed 2026-05-15 | 11.09M shares derived: average of 3 quarters · filed 2026-05-15 | 11.02M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 11.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 11.01M shares derived: average of 2 quarters · filed 2026-03-30 | 10.94M shares derived: average of 3 quarters · filed 2026-08-14 | 10.90M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 10.83M shares 10-Q · filed 2025-11-12 | 10.81M shares derived: average of 2 quarters · filed 2026-08-14 | 10.80M shares 10-Q · filed 2025-11-12 | 10.80M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 10.78M shares 10-Q · filed 2026-08-14 | 10.78M shares 10-Q · filed 2026-08-14 | 10.78M shares derived: average of 3 quarters · filed 2026-08-14 | 10.78M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 10.78M shares 10-Q · filed 2026-05-15 | 10.78M shares derived: average of 2 quarters · filed 2026-05-15 | 10.78M shares derived: average of 3 quarters · filed 2026-05-15 | 10.77M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 10.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 10.77M shares derived: average of 2 quarters · filed 2026-03-30 | 10.77M shares derived: average of 3 quarters · filed 2026-03-30 | 10.76M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 10.76M shares 10-Q · filed 2025-11-12 | 10.76M shares derived: average of 2 quarters · filed 2025-11-12 | 10.76M shares 10-Q · filed 2025-11-12 | 10.77M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 10.76M shares 10-Q · filed 2025-08-13 | 10.75M shares 10-Q · filed 2025-08-13 | 10.77M shares derived: average of 3 quarters · filed 2025-08-13 | 10.79M shares derived: average of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | 10.74M shares 10-Q · filed 2025-05-15 | 10.77M shares derived: average of 2 quarters · filed 2025-05-15 | 10.80M shares derived: average of 3 quarters · filed 2025-05-15 | 10.81M shares derived: average of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | 10.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 10.83M shares derived: average of 2 quarters · filed 2025-03-27 | 10.84M shares derived: average of 3 quarters · filed 2025-03-27 | 10.84M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 10.86M shares 10-Q · filed 2024-11-07 | 10.86M shares derived: average of 2 quarters · filed 2024-11-07 | 10.86M shares 10-Q · filed 2024-11-07 | 10.86M shares derived: average of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 10.86M shares 10-Q · filed 2024-08-08 | 10.86M shares 10-Q · filed 2024-08-08 | 10.86M shares derived: average of 3 quarters · filed 2024-08-08 | 10.85M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 10.86M shares 10-Q · filed 2024-05-09 | 10.86M shares derived: average of 2 quarters · filed 2024-05-09 | 10.85M shares derived: average of 3 quarters · filed 2024-05-09 | 10.85M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 10.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | 10.85M shares derived: average of 2 quarters · filed 2024-03-18 | 10.84M shares derived: average of 3 quarters · filed 2024-03-18 | 10.85M shares 10-K · filed 2024-03-18 |
| 2022-09-30 | 10.84M shares 10-Q · filed 2023-11-08 | 10.83M shares derived: average of 2 quarters · filed 2023-11-08 | 10.85M shares 10-Q · filed 2023-11-08 | 10.93M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 10.83M shares 10-Q · filed 2023-08-09 | 10.85M shares 10-Q · filed 2023-08-09 | 10.96M shares derived: average of 3 quarters · filed 2023-08-09 | 11.01M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 10.88M shares 10-Q · filed 2023-05-09 | 11.02M shares derived: average of 2 quarters · filed 2023-05-09 | 11.08M shares derived: average of 3 quarters · filed 2023-05-09 | 11.10M shares derived: average of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 11.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 11.18M shares derived: average of 2 quarters · filed 2023-03-20 | 11.18M shares derived: average of 3 quarters · filed 2023-03-20 | 10.90M shares 10-K · filed 2023-03-20 |
| 2021-09-30 | 11.19M shares 10-Q · filed 2022-11-07 | 11.18M shares derived: average of 2 quarters · filed 2022-11-07 | 10.82M shares 10-Q · filed 2022-11-07 | |
| 2021-06-30 | 11.18M shares 10-Q · filed 2022-08-08 | 10.63M shares 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | 10.07M shares 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |